Los Angeles Capital Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-53,113
Closed -$782K 1242
2024
Q1
$782K Sell
53,113
-7,216
-12% -$109K ﹤0.01% 761
2023
Q4
$580K Hold
60,329
﹤0.01% 824
2023
Q3
$281K Buy
+60,329
New +$300K ﹤0.01% 975
2021
Q3
Sell
-10,898
Closed -$293K 1549
2021
Q2
$293K Sell
10,898
-14,208
-57% -$416K ﹤0.01% 1396
2021
Q1
$800K Sell
25,106
-6,360
-20% -$154K ﹤0.01% 1003
2020
Q4
$719K Buy
+31,466
New +$724K ﹤0.01% 1066
2019
Q2
Sell
-23,865
Closed -$429K 1390
2019
Q1
$429K Sell
23,865
-57,100
-71% -$987K ﹤0.01% 1129
2018
Q4
$1.03M Buy
80,965
+5,115
+7% +$85.8K 0.01% 730
2018
Q3
$1.63M Buy
75,850
+46,270
+156% +$986K 0.01% 726
2018
Q2
$611K Buy
+29,580
New +$666K ﹤0.01% 1075
2017
Q4
Sell
-31,210
Closed -$577K 1361
2017
Q3
$577K Buy
31,210
+5,050
+19% +$87.5K ﹤0.01% 979
2017
Q2
$458K Buy
+26,160
New +$499K ﹤0.01% 960

Other funds holding MGNX

Los Angeles Capital Management's MGNX Position: Q2 2024 in Review

Los Angeles Capital Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 53,113 shares — an estimated $782K sold.

Los Angeles Capital Management first reported a position in MGNX in Q2 2017 and held it in 12 quarters. The position peaked at $1.63M in Q3 2018. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Los Angeles Capital Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 53,113 MacroGenics shares in Q2 2024, an estimated $782K.
  • Los Angeles Capital Management first reported a position in MacroGenics in Q2 2017 and held it in 12 quarters.
  • Los Angeles Capital Management's MacroGenics position peaked at $1.63M in Q3 2018.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Los Angeles Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.